Trials / Sponsors / Claire Verschraegen
Claire Verschraegen
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer Merkel Cell Carcinoma, Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8 | Phase 1 | 2019-01-07 |